Implications of the angiotensinogen gene in blood pressure regulation;Die rolle des angiotensinogengens fur die essentielle hypertonie

Herz

Volumn 25, Issue 1, 2000, Pages 15-25

  Brand, Eva ^b   Ringel, Jens ^b   Sharma, Arya M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Angiotensinogen; Essential hypertension; Functional promoter analyses; Genetic polymorphisms; Linkage studies

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; RENIN;

ALLELISM; ARTICLE; BLOOD PRESSURE REGULATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ALLELE; CASE CONTROL STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; OBESITY; PREECLAMPSIA; PREGNANCY; REVIEW;

ALLELES; ANGIOTENSINOGEN; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; OBESITY; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY;

EID: 0034132786     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03044120     Document Type: Article

References (98)

1. Arngrimsson R, Purandare S, Connor M, et al. Angiotensinogen: a candidate gene involved in preeclampsia? Nat Genet 1993;4:114-5.
2. Beige J, Weber A, Engeli S, et al. Angiotensinogen-M235T genotype and post-transplant hypertension. Nephrol Dial Transplant 1996;11:1538-41.
3. Beige J, Zilch O, Hohenbleicher H, et al. Genetic variants of the renin-angiotensin system and ambulatory blood pressure in essential hypertension. J Hypertens 1997;15:503-8.
4. Bennett CL, Schrader AP, Morris BJ. Cross-sectional analysis of Met235→Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun 1993;197:833-9.
5. Bloem U, Manatunga AK, Tewksbury DA, et al. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995;95: 948-53.
6. Brand E, Chatelain N, Keavney B, et al. Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension 1998;31:725-9.
7. Brand E, Chatelain N, Paillard F, et al. Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis. Hum Mol Genet (submitted).
8. Brasier AR, Li JY. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 1996;27:465-75.
9. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986;78:31-9.
10. Campbell DJ, Habener JF. Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 1987;121:1616-26.
11. Campbell-Boswell M, Robertson AL Jr. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 1981;35:265-76.
12. Cassis LA. Downregulation of the renin-angiotensin system in streptozotocin-diabetic rats. Am J Physiol 1992;262:E105-9.
13. Cassis LA, Saye J, Peach MJ. Location and regulation of rat angiotensinogen messenger RNA. Hypertension 1988;11:591-6.
14. Caulfield M, Lavender P, Farrall M, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1629-33.
15. Caulfield M, Lavender P, Newell-Price J. et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995;96:687-92.
16. Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986; 93:898-908.
17. Clauser E, Gaillard I, Wei L, et al. Regulation of angiotensinogen gene. Am J Hypertens 1989;2:403-10.
18. Danser AH, Derkx FH, Hense HW, et al. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 1998; 16:1879-83.
19. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988;77:14-13.
20. Eaton SB, Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med 1985;312:283-9.
21. Engeli S, Gorzelniak K, Kreutz R, et al. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999;17:555-60.
22. Fasola AF, Martz BL, Helmer OM. Renin activity during supine exercise in normotensives and hypertensives. J Appl Physiol 1966; 21:1709-12.
23. Fornage M, Turner ST, Sing CF, et al. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: A population-based case-control study from Rochester, Minnesota. Hum Genet 1995;96:295-300.
24. Frederich RC, Jr., Kahn BB, Peach MJ, et al. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992;19:339-44.
25. Fukamizu A, Sugimura K, Takimoto E, et al. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 1993;268:11617-21.
26. Fukamizu A, Takahashi S, Seo MS, et al. Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter. J Biol Chem 1990;265:7576-82.
27. Fukamizu A, Seo MS, Hatae T, et al. Tissue-specific expression of the human renin gene in transgenic mice. Biochem Biophys Res Commun 1989;165:826-32.
28. Gaillard I, Clauser E, Corvol P. Structure of human angiotensinogen gene. DNA 1989;8:87-99.
29. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988;62:749-56.
30. Giacchetti G, Faloia E, Sardu C, et al. Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obesity 1998;22: S102.
31. Gomez RA, Lynch KR, Chevalier RL, et al. Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol 1988:254:F900-6.
32. Griffin SA, Brown WC, MacPherson F, et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991;17:626-35.
33. Hata A, Namikawa C, Sasaki M, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;93: 1285-7.
34. Hingorani AD, Sharma P, Jia HY, et al. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996;28:907-11.
35. Hsueh WA, Buchanan TA. Obesity and hypertension. Endocrinol Metab Clin 1994;23:405-27.
36. Huang Z, Willett WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998;128: 81-8.
37. Hunt SC, Geleijnse JM, Wu LL, et al. Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene. Am J Hypertens 1999;12:460-6.
38. Hübner N, Kreutz R, Takahashi S, et al. Unlike human hypertension, blood pressure in a hereditary hypertensive rat strain shows no linkage to the angiotensinogen locus. Hypertension 1994;23: 797-801.
39. Inouel, Nakajima T, Williams CS, et al. Anucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786-97.
40. Ishigami T, Umemura S, Tamura K, et al. Essential hypertension and 5' upstream core promoter region of human angiotensinogen gene. Hypertension 1997;30:1325-30.
41. Jeunemaitre X, Menard J, Clauser E, et al. Angiotensinogen: molecular biology and genetics. In: Laragh JH, Brenner BM, eds. Pathophysiology, diagnosis and management in Hypertension, Vol 2. New York: Raven, 1995:1653-65.
42. Jeunemaitre X, Charru A, Chatellier G, et al. M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993;11:Suppl 5:S80-1.
43. Jeunemaitre X, Inoue I, Williams C, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997;60: 1448-60.
44. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71: 169-80.
45. Johnson AG, Simons LA, Friedlander Y, et al. M235→T polymorphism of the angiotensinogen gene predicts hypertension in the elderly. J Hypertens 1996;14:1061-5.
46. Jones BH, Standridge MK, Taylor JW, et al. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am J Physiol 1997; 273:R236-42.
47. Kamitani A, Rakugi H, Higaki J, et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994;8:521-4.
48. Karlsson C, Lindell K, Ottosson M, et al. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998; 83: 3925-9.
49. Kawahara Y, Sunako M, Tsuda T, et al. Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1988;150:52-9.
50. Kiema TR, Kauma H, Rantala AO, et al. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996;28:1070-5.
51. Kim H-S, Krege JH, Kluckman KD, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995;92:2735-9.
52. Kimura S, Mullins JJ, Bunnemann B, et al. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J 1992;11:821-7.
53. Knoll A, Schunkert H, Reichwald K, et al. Human renin binding protein: complete genomic sequence and association of an intronic T/C polymorphism with the prorenin level in males. Hum Mol Genet 1997;6:1527-34.
54. Kotelevtsev YuV, Clauser E, Corvol P, et al. Dinucleotide repeat polymorphism in the human angiotensinogen gene. Nucl Acids Res 1991;19:6978.
55. Kunz R, Kreutz R, Beige J, et al. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30:1331-7.
56. Lachurie ML, Azizi M, Guyene TT, et al. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995;91:2933-42.
57. Lebrun CJ, Blume A, Herdegen T, et al. Angiotensin II induces a complex activation of transcription factors in the rat brain: expression of Fos, Jun and Krox proteins. Neuroscience 1995;65:93-9.
58. Licata G, Scaglione R, Corrao S, et al. Heredity and obesity-associated hypertension: Impact of hormonal characteristics and left ventricular mass. J Hypertens 1995;13:611-8.
59. Licata G, Scaglione R, Ganguzza A, et al. Central obesity and hypertension: Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens 1994;7:314-20.
60. Lodwick D, Kaiser MA, Harris J, et al. Analysis of the role of angiotensinogen in spontaneous hypertension. Hypertension 1995;25: 1245-51.
61. McGehee REJ, Ron D, Brasier AR, et al. Differentiation-specific element: a cis-acting developmental switch required for the sustained transcriptional expression of the angiotensinogen gene during hormonal-induced differentiation of 3T3-L1 fibroblasts to adipocytes. Mol Endocrinol 1993;7:551-60.
62. Morgan L, Pipkin FB, Kalsheker N. DNA polymorphisms and linkage disequilibrium in the angiotensinogen gene. Hum Genet 1996;98:194-8.
63. Nibu Y, Takahashi S, Tanimoto K, et al. Identification of cell type-dependent enhancer core element located in the 3′-downstream region of the human angiotensinogen gene. J Biol Chem 1994; 269:28598-605.
64. Nibu Y, Tanimoto K, Takahashi S, et al. A cell type-dependent enhancer core element is located in exon 5 of the human angiotensinogen gene. Biochem Biophys Res Commun 1994;205:1102-8.
65. Nishimura H, Hoffmann S, Baltatu O, et al. Angiotensin I converting enzyme and chymase in cardiovascular tissues. Kidney Int 1996;55:Suppl:S18-23.
66. Nishiuma S, Kario K, Kayaba K, et al. Effect of the angiotensinogen gene Met235→Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 1995; 13:717-722.
67. Niu TH, Xu XP, Rogus J, et al. Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998;101:188-94.
68. Ohkubo H, Kawakami H, Kakehi Y, et al. Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Natl Acad Sci USA 1990;87:5153-7.
69. Orita M, Iwahana H, Kanazawa H, et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989;86: 2766-70.
70. Paillard F, Chansel D, Brand E, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999;34:423-9.
71. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993; 119:655-60.
72. Rotimi C, Cooper R, Ogunbiyi O, et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997;95:2348-50.
73. Rotimi C, Morrison L, Cooper R, et al. Angiotensinogen gene in human hypertension: Lack of an association of the 235T allele among African Americans. Hypertension 1994;24:591-4.
74. Rotimi C, Puras A, Cooper R, et al. Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension 1996;27:558-63.
75. Sato N, Katsuya T, Rakugi H, et al. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension 1997;30: 321-5.
76. Schling P, Mallow H, Trindl A, et al. Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes 1999;23:336-41.
77. Schmidt S, Sharma AM, Zilch O, et al. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995;10:1145-8.
78. Schorr U, Blaschke K, Beige J, et al. Angiotensinogen M235T variant and salt sensitivity in young normotensive Caucasians. J Hypertens 1999;17:475-9.
79. Schorr U, Blaschke K, Turan S, et al. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men. J Hypertens 1998;16:1475-80.
80. Sharma AM. Salt sensitivity as a phenotype for genetic studies of human hypertension. Nephrol Dial Transplant 1996;11:927-9.
81. Sharma AM. The thrifty-genotype hypothesis and its implications for the study of complex genetic disorders in man. J Mol Med 1998;76:568-71.
82. Sutherland A, Cooper DW, Howie PW, et al. The indicence of severe pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls. Br J Obstet Gynaecol 1981;88:785-91.
83. Tamura K, Umemura S, Ishii M, et al. Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter. J Clin Invest 1994;93:1370-9.
84. Tamura K, Umemura S, Iwamoto T, et al. Molecular mechanism of adipogenic activation of the angiotensinogen gene. Hypertension 1994;23:364-8.
85. Tamura K, Umemura S, Nyui N, et al. Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension 1996;27:1216-23.
86. Tamura K, Umemura S, Yamakawa T, et al. Modulation of tissue angiotensinogen gene expression in genetically obese hypertensive rats. Am J Physiol 1997;272:R1704-11.
87. Tanimoto K, Sugiyama F, Goto Y, et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem 1994;269:31334-7.
88. Taubman MB, Berk BC, Izumo S, et al. Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem 1989;264:526-30.
89. Tiret L, Ricard S, Poirier O, et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: The ECTIM study. J Hypertens 1995;13:311-7.
90. Tuck ML, Sowers J, Dornfeld L, et al. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981;304:930-3.
91. Umemura S, Nyui N, Tamura K, et al. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997;10:629-33.
92. Walker WG, Whelton PK, Saito H, et al. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979;1:287-91.
93. Ward K, Hata A, Jeunemaitre X, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993; 4:59-61.
94. Watt GC, Harrap SB, Foy CJ, et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992;10:473-82.
95. Weinberger MH. Salt sensitive human hypertension. Endocr Res 1991;17:43-51.
96. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996;27:481-90.
97. Yanai K, Nibu Y, Murakami K, et al. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J Biol Chem 1996;271:15981-6.
98. Zhao YY, Zhou J, Kumar A, et al. Molecular mechanism of human essential hypertension. A mutation in the proximal promoter of the angiotensinogen gene from hypertensive patients increases its transcription in human hepatoma cells. Circulation 1996;94: 1693.